Science Explorer Back to mapMap
Discussion
Researcher · NKT Therapeutics (United States) · United States

Lukas Dillinger

Lukas Dillinger publishes mostly in Immunology, Surgery and Oncology, on topics such as IL-33, ST2, and ILC Pathways, Monoclonal and Polyclonal Antibodies Research and Eosinophilic Esophagitis.

OpenAlex
World rank
#6,243,938
of 7,710,434 ranked researchers
Rank in United States
#1,494,172
of 1,627,098
Works
16
Citations
30
Citations per work
1.9
h-index
3
i10-index 1Top 99% in Immunology
Lukas Dillinger

What does Lukas Dillinger research?

Lukas Dillinger's work is mostly in Immunology and Microbiology (39%), Medicine (33%), Biochemistry, Genetics and Molecular Biology (6%).

Life Sciences: 7 works · 45.6% of their workImmunology and Microbiology: 6 works · 39.1% of their workImmunology: 6 works · 39.1% of their workBiochemistry, Genetics and Molecular Biology: 1 works · 6.5% of their workMolecular Biology: 1 works · 6.5% of their workHealth Sciences: 5 works · 32.6% of their workMedicine: 5 works · 32.6% of their workOncology: 1 works · 8.7% of their workRadiology, Nuclear Medicine and Imaging: 1 works · 8.7% of their workSurgery: 1 works · 8.7% of their workDermatology: 1 works · 6.5% of their workEverything else: 3 works · 21.8% of their workTHEIR WORKLukas Dillinger16works
Life Sciences46%Health Sciences33%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology639.1%
    2. Biochemistry, Genetics and Molecular Biology16.5%
    1. Medicine532.6%
  3. Everything else321.8%
  1. 1Immunology39% of their works
  2. 2Surgery9% of their works
  3. 3Oncology9% of their works
  4. 4Radiology, Nuclear Medicine and Imaging9% of their works
  5. 5Dermatology6% of their works
  6. 6Molecular Biology6% of their works

Research topics

Which keywords describe Lukas Dillinger's research?

The keywords of their largest research topics: Regulatory T Cells, Glycosylation, IL-33, Innate Lymphoid Cells, Immune Dysregulation, Immune System, TGF-ß and Diagnosis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Regulatory T Cells92 topics
  2. Glycosylation62 topics
  3. IL-3361 topic
  4. Innate Lymphoid Cells61 topic
  5. Immune Dysregulation52 topics
  6. Immune System52 topics
  7. TGF-ß52 topics
  8. Diagnosis41 topic
  9. Eosinophilic Esophagitis41 topic
  10. Fc Receptors41 topic
  11. Therapeutic Antibodies41 topic
  12. Filaggrin31 topic
  13. IL-1731 topic
  14. Skin Microbiome31 topic
  15. TH17 Cells31 topic
  16. CD4+CD25+21 topic
  17. Cancer21 topic
  18. Foxp321 topic
  19. Genetic Mutations21 topic
  20. Glycans21 topic
  21. Primary Immunodeficiency21 topic

Where does Lukas Dillinger work?

Lukas Dillinger's main affiliation in the publication record is NKT Therapeutics (United States), United States.

How many publications and citations does Lukas Dillinger have?

OpenAlex counts 16 works and 30 citations for Lukas Dillinger, an h-index of 3, ranking #6,243,938 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Lukas Dillinger. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.